Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement
Navigating HER2+ Metastatic Breast Cancer Treatment : Episode 7

Opinion

Video

November 30, 2023

Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

Author(s):

Sara M. Tolaney, MD, MPH

Treatment for HER2 low metastatic breast cancer may utilize HER2-targeted antibody-drug conjugates like T-DM1 and sacituzumab govitecan after initial therapy; knowing HER2 status, even low expression, is critical to guide use of these HER2-directed ADCs after chemotherapy.

EP: 1.The Role of the HER2 Receptor in Breast Cancer

EP: 2.Necessary Tests After a Diagnosis of Breast Cancer

EP: 3.Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

EP: 4.Discussing Clinical Trial Enrollment for HER2-Positive Metastatic Breast Cancer With Your Oncologist

EP: 5.Guideline-Recommended Treatments for HER2-Positive Metastatic Breast Cancer

EP: 6.Guideline-Recommended Treatments for HER2-Negative Metastatic Breast Cancer

Now Viewing

EP: 7.Guideline-Recommended Treatments for HER2-Low Metastatic Breast Cancer

EP: 8.How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer

EP: 9.Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response

EP: 10.Potential Severe Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

EP: 11.Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Hideko Warner
Picture of LaShae D. Rolle
Photo of Jake Messier
Related Content
Advertisement
Image of women with text.
August 15th 2025

Breast Cancer Survivor Shares Benefits of Strength Training on Chemo

Ryan Scott
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 15th 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date: © stock.adobe.com.
August 15th 2025

FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

Spencer Feldman
Cancer Horizons podcast logo
August 15th 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer: © stock.adobe.com.
August 15th 2025

Gut Bacteria May Help Predict Heart Risks in Breast Cancer Treatment

Spencer Feldman
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
August 15th 2025

A Moment of Kindness I’ll Never Forget During Cancer Treatment

Laura Yeager
Related Content
Advertisement
Image of women with text.
August 15th 2025

Breast Cancer Survivor Shares Benefits of Strength Training on Chemo

Ryan Scott
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 15th 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date: © stock.adobe.com.
August 15th 2025

FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

Spencer Feldman
Cancer Horizons podcast logo
August 15th 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer: © stock.adobe.com.
August 15th 2025

Gut Bacteria May Help Predict Heart Risks in Breast Cancer Treatment

Spencer Feldman
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
August 15th 2025

A Moment of Kindness I’ll Never Forget During Cancer Treatment

Laura Yeager
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.